MYMD Cash Flow Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
Report Filing: 2024-04-01 2023-11-14 2023-08-14 2023-05-15 2023-03-31 2022-11-10
1234
Net Income/Starting Line -2363559 4042994 -4167653 -1511732 -3745518 -3693741
1234
Cash From Operating Activities -1932630 -3156478 -3919875 -3971642 -2248404 -4087419
1234
Depreciation and Amortization 0 0 0 0 0 0
1234
Deferred Income Tax 0 0 0 0 0 0
1234
Stock Based Compensation 1619844 385143 1024642 19908 45222 85368
1234
Other Non-Cash Items -3341337 -7714291 -786499 -1003603 68216 266350
1234
Changes in Working Capital 2152422 129676 9635 -1476215 1383676 -745396
1234
Accounts Receivable 0 0 0 0 0 0
1234
Inventory 0 0 0 0 0 0
1234
Accounts Payable 1682378 -122612 787252 -1304021 955912 -1124226
1234
Deferred Revenue 470044 252288 -777617 -172194 427764 378830
1234
Other Working Capital 0 0 0 0 0 0
1234
Cash From Investing Activities 5934192 3360973 3825150 -11274589 2687568 -2267857
1234
Investments in Property Plant and Equipment 0 0 0 0 0 0
1234
Payments for Acquisitions 0 0 0 0 0 0
1234
Purchases of Securities -115838 -139057 -174850 -13024559 -62432 -4767857
1234
Proceeds from Sales and Maturities of Securities 6050030 3500030 4000000 1749970 2750000 2500000
1234
Other Investing Activities 5934.192 3360.973 3825.1499999999996 -11274.589 2687.568 -2267.857
1234
Cash From Financing Activities -1618870 6 -174851 14685689 0 5550028
1234
Debt Repayment 0 -6 -5 -157 0 -943
1234
Common Stock Issued 0 0 14510833 14685689 5550028 5550028
1234
Common Stock Repurchased -89635 0 -14685689 -157 0 0
1234
Dividends Paid 0 0 0 0 0 0
1234
Other Financing Activities -77090 12 174861 158647 -5550028 943
1234
Effect of Forex Changes on Cash 0 -6 174851 0 0 0
1234
Net Change in Cash 2382692 204495 -94725 -560542 439164 -805248
1234
Cash at Beginning of Period 298318 93823 188548 749090 309926 1115174
1234
Cash at End of Period 2681010 298318 93823 188548 749090 309926
1234
Free Cash Flow -1932630 -3156478 -3919875 -3971642 -2248404 -4087419
1234
Operating Cash Flow -1932630 -3156478 -3919875 -3971642 -2248404 -4087419
1234
Capital Expenditure 0 0 0 0 0 0
1234

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.